Status:
COMPLETED
Covid-19 Vaccine Response in Heart Transplant Recipients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Heart Transplantation
COVID-19 Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Clinical studies indicate a decrease in vaccine efficacy in certain immunocompromised populations (kidney transplant recipients, patients undergoing chemotherapy). It was recently reported that only 1...
Detailed Description
In order to evaluate the effectiveness and safety of currently adopted vaccination strategies in heart transplant recipients we intend to study the humoral and cellular responses to SARS-CoV-2 mRNA va...
Eligibility Criteria
Inclusion
- Heart transplant patients followed at Bichat Hospital
- Aged 18 or older
- Informed and having expressed their non-objection to participation in this research
- Able to give their agreement
Exclusion
- Minors
- Heart transplant recipients who have expressed their opposition to their participation
- Legally protected adult
- Persons under the State Medical Assistance (AME)
Key Trial Info
Start Date :
March 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT05268679
Start Date
March 7 2022
End Date
November 30 2022
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP, Bichat-Claude Bernard Hospital
Paris, France, 75018